{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:12:53Z","timestamp":1776417173310,"version":"3.51.2"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research","award":["2022-PUMCH-C-037"],"award-info":[{"award-number":["2022-PUMCH-C-037"]}]},{"name":"National High Level Hospital Clinical Research","award":["2022-PUMCH-B-098"],"award-info":[{"award-number":["2022-PUMCH-B-098"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Inflammation plays important roles in the pathogenesis of both de novo and restenotic lesions in coronary artery disease (CAD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>This patient was a middle-aged female who had few risk factors for atherosclerotic CAD (AS-CAD) but prior history of psoriasis and elevated erythrocyte sedimentation rate. The patient experienced four ischaemia-driven hospitalizations and\/or percutaneous coronary interventions (PCIs) within 18 months due to new-onset or worsened coronary de novo and\/or restenotic lesions, especially recurrent restenosis at the same vessel segment, despite optimal PCI and strict secondary prevention for AS-CAD. The patient received: (i) ischaemia-driven (least-necessary) and restricted (least-invasive) PCI, which relieved severe anginal symptoms and (ii) immunosuppressive therapy, which was associated with delayed progression and even partial regression of the coronary lesions, as well as reduced need for further ischaemia-driven hospitalization and\/or revascularization during a 40-month follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We propose to use inflammation-associated rapidly progressive CAD (IR-CAD) to define the disease entity of this patient. Both systemic inflammation and local vascular inflammation secondary to local vascular mechanical injury, such as that induced by PCI per se, might contribute to the pathogenesis of IR-CAD. Immunosuppressive therapy (to control inflammation) together with ischaemia-driven and restricted PCI (to relieve severe myocardial ischaemia and avoid unnecessary vascular mechanical injury) might be crucial to the treatment of IR-CAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag177","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:23:00Z","timestamp":1773058980000},"source":"Crossref","is-referenced-by-count":0,"title":["Inflammation-associated rapidly progressive coronary artery disease: a case report"],"prefix":"10.1093","volume":"10","author":[{"given":"Liang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , No.1 Shuaifuyuan, Dongcheng District, Beijing 100730 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-5777","authenticated-orcid":false,"given":"Zhenyu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , No. 1 Shuaifuyuan, Dongcheng District, Beijing 100730 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2026041704171364400_ytag177-B1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/CIRCRESAHA.118.313591","article-title":"Immunity and inflammation in atherosclerosis","volume":"124","author":"Wolf","year":"2019","journal-title":"Circ Res"},{"key":"2026041704171364400_ytag177-B2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrcardio.2011.132","article-title":"Restenosis after PCI. Part 1: pathophysiology and risk factors","volume":"9","author":"Jukema","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"2026041704171364400_ytag177-B3","doi-asserted-by":"crossref","first-page":"104130","DOI":"10.1016\/j.jaccas.2025.104130","article-title":"Evolution of inflammation-associated coronary artery disease on immunosuppressive therapy","volume":"30","author":"Wang","year":"2025","journal-title":"JACC Case Rep"},{"key":"2026041704171364400_ytag177-B4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jcin.2011.05.025","article-title":"Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis","volume":"4","author":"Inoue","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"2026041704171364400_ytag177-B5","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jacc.2022.05.017","article-title":"Coronary in-stent restenosis: JACC state-of-the-art review","volume":"80","author":"Giustino","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026041704171364400_ytag177-B6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jacc.2003.09.054","article-title":"Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)","volume":"43","author":"Albiero","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"2026041704171364400_ytag177-B7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jcin.2017.04.024","article-title":"Neointimal modification with scoring balloon and efficacy of drug-coated balloon therapy in patients with restenosis in drug-eluting coronary stents: a randomized controlled trial","volume":"10","author":"Kufner","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"2026041704171364400_ytag177-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ehjcr\/ytaa011","article-title":"Coronary arteritis: a case series","volume":"4","author":"Kikuchi","year":"2020","journal-title":"Eur Heart J Case Rep"},{"key":"2026041704171364400_ytag177-B9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2013.06.053","article-title":"Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors","volume":"69","author":"Miller","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2026041704171364400_ytag177-B10","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.immuni.2025.09.012","article-title":"Inflammation in atherosclerosis: lessons and therapeutic implications","volume":"58","author":"Libby","year":"2025","journal-title":"Immunity"},{"key":"2026041704171364400_ytag177-B11","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ehjcvp\/pvy036","article-title":"Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge","volume":"5","author":"Borovac","year":"2019","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026041704171364400_ytag177-B12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","article-title":"Inflammation in obesity, diabetes, and related disorders","volume":"55","author":"Rohm","year":"2022","journal-title":"Immunity"},{"key":"2026041704171364400_ytag177-B13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41574-023-00932-2","article-title":"Emerging mechanisms of obesity-associated immune dysfunction","volume":"20","author":"Shaikh","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026041704171364400_ytag177-B14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","article-title":"Inflammation and resolution in obesity","volume":"21","author":"Sot\u00e1k","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"2026041704171364400_ytag177-B15","doi-asserted-by":"crossref","first-page":"102102","DOI":"10.1016\/j.jaccas.2023.102102","article-title":"Isolated coronary arteritis treated with FDG-PET\/CT-guided immunosuppressant to break the vicious cycle of in-stent restenosis","volume":"28","author":"Takasaki","year":"2023","journal-title":"JACC Case Rep"},{"key":"2026041704171364400_ytag177-B16","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s12265-023-10388-4","article-title":"Isolated coronary arteritis in adults: a single-center experience from China","volume":"16","author":"Liu","year":"2023","journal-title":"J Cardiovasc Transl Res"},{"key":"2026041704171364400_ytag177-B17","first-page":"004412","article-title":"Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies","volume":"11","author":"Tomberli","year":"2024","journal-title":"Eur J Case Rep Intern Med"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag177\/67287418\/ytag177.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/4\/ytag177\/68101933\/ytag177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/4\/ytag177\/68101933\/ytag177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:17:57Z","timestamp":1776413877000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag177\/8512847"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Eitaro","family":"Kodani","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag177","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,10]]},"article-number":"ytag177"}}